BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16359237)

  • 1. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
    Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
    Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
    Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
    Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization.
    Puttikhunt C; Kasinrerk W; Srisa-ad S; Duangchinda T; Silakate W; Moonsom S; Sittisombut N; Malasit P
    J Virol Methods; 2003 Apr; 109(1):55-61. PubMed ID: 12668268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
    Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
    Front Immunol; 2019; 10():1522. PubMed ID: 31333657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.
    Costa SM; Paes MV; Barreto DF; Pinhão AT; Barth OM; Queiroz JL; Armôa GR; Freire MS; Alves AM
    Vaccine; 2006 Jan; 24(2):195-205. PubMed ID: 16122850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice.
    Wu SF; Liao CL; Lin YL; Yeh CT; Chen LK; Huang YF; Chou HY; Huang JL; Shaio MF; Sytwu HK
    Vaccine; 2003 Sep; 21(25-26):3919-29. PubMed ID: 12922127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inoculation of plasmid expressing the dengue 2 NS1 gene elicits immunity in mice].
    Yang CY; Chen Y; Yan HJ; Fang DY; Xue YH; Jiang LF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):71-3. PubMed ID: 16201480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains.
    Lim CS; Chua JJ; Wilkerson J; Chow VT
    Viral Immunol; 2006; 19(1):33-41. PubMed ID: 16553548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
    Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S; Khanna N; Swaminathan S
    Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection.
    Lima DM; de Paula SO; França RF; Palma PV; Morais FR; Gomes-Ruiz AC; de Aquino MT; da Fonseca BA
    Vaccine; 2011 Jan; 29(4):831-8. PubMed ID: 21115054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus.
    Bailey MJ; Broecker F; Duehr J; Arumemi F; Krammer F; Palese P; Tan GS
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.
    Raviprakash K; Kochel TJ; Ewing D; Simmons M; Phillips I; Hayes CG; Porter KR
    Vaccine; 2000 May; 18(22):2426-34. PubMed ID: 10738100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.